OxyContin Oxycodone OP 30 mg 100 Tablets

What is OxyContin?

Brown OxyContin is a brand name for the prescription pain medication oxycodone hydrochloride. The OP designation indicates that this is a controlled-release (extended-release) tablet that includes abuse-deterrent properties. The 30mg strength is used for the management of moderate to severe pain that requires continuous, around-the-clock opioid treatment for an extended period of time. Buy helpful reliable OxyContin Oxycodone OP 30mg for chronic pain safely from tabletspharmacy.com over the counter with fast and easy free delivery. Buy with secure payment.

Attention Dispenser: Accompanying Medication Guide must be provided to the patient upon dispensing.

NDC 59011-430-10

OxyContin®
(oxycodone hydrochloride)
extended-release tablets

30 mg

100 Tablets  Rx Only

Usual Dosage: Read accompanying prescribing information.
Swallow tablets whole. Do not cut, break, crush, or dissolve.

Dispense in a tight, light-resistant container.
Store at 15°–30°C (59°–86°F).
[See USP Controlled Room Temperature.]

Purdue Pharma L.P.
Stamford, CT 06901-3431
302979-0F

(Barcode: 3 59011 43010 8)

OxyContin Side Effects

OxyContin is an opioid with a high risk of adverse effects, including the most severe risks of addiction, abuse, misuse, and life-threatening respiratory depression (slowed or stopped breathing). The risk is particularly high if the tablet is crushed or dissolved, overriding the controlled-release mechanism.

Common Side Effects:

• Constipation (very common and often requires prophylactic treatment)

• Nausea and Vomiting

• Somnolence drowsiness and Dizziness

• Pruritus itching

• Headache, Dry mouth, Sweating

  Serious Side Effects and Risks:

• Respiratory Depression: The most dangerous risk, characterized by slow, shallow breathing, which can lead to death.

• Overdose: Symptoms include extreme drowsiness, inability to wake up, pinpoint pupils, cold/clammy skin, and loss of consciousness.

Oxycodone vs OxyContin

• The family has faced extensive litigation and agreed to relinquish ownership of Purdue Pharma and contribute billions of dollars toward efforts to address the opioid crisis.